Diagnosis of HDV: From Virology to Non-invasive Markers of Fibrosis

Overview

Journal Liver Int

Specialty Gastroenterology

Date 2023 Jan 9

PMID 36621853

Authors

Nehna Abdul Majeed

Asif A Hitawala

Theo Heller

Christopher Koh

Affiliations

Soon will be listed here.

Abstract

Hepatitis D viral infection in humans is a disease that requires the establishment of hepatitis B, relying on hepatitis B surface Ag and host cellular machinery to replicate and propagate the infection. Since its discovery in 1977, substantial progress has been made to better understand the hepatitis D viral life cycle, pathogenesis and modes of transmission along with expanding on clinical knowledge related to prevention, diagnosis, monitoring and treatment. The availability of serologic diagnostic assays for hepatitis D infection has evolved over time with current widespread availability, improved detection and standardized reporting. With human migration, the epidemiology of hepatitis D infection has changed over time. Thus, the ability to use diagnostic assays remains essential to monitor the global impact of hepatitis D infection. Separately, while liver biopsy remains the gold standard for the staging of this rapidly progressive and severe form of chronic viral hepatitis, there is an unmet need for clinical monitoring of chronic hepatitis D infection for management of progressive disease. Thus, exploration of the utility of non-invasive fibrosis markers in hepatitis D is ongoing. In this review, we discuss the virology, the evolution of diagnostics and the development of non-invasive markers for the detection and monitoring of fibrosis in patients with hepatitis D infection.

Citing Articles

Current perspectives of viral hepatitis.

Usuda D, Kaneoka Y, Ono R, Kato M, Sugawara Y, Shimizu R World J Gastroenterol. 2024; 30(18):2402-2417.

PMID: 38764770 PMC: 11099385. DOI: 10.3748/wjg.v30.i18.2402.

Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies.

Gopalakrishna H, Mironova M, Dahari H, Koh C, Heller T Curr Hepatol Rep. 2024; 23(1):32-44.

PMID: 38533303 PMC: 10965034. DOI: 10.1007/s11901-024-00643-w.

References

Katsoulidou A, Manesis E, Rokka C, Issaris C, Pagoni A, Sypsa V . Development and assessment of a novel real-time PCR assay for quantitation of hepatitis D virus RNA to study viral kinetics in chronic hepatitis D. J Viral Hepat. 2013; 20(4):256-62. DOI: 10.1111/jvh.12000. View

El Bouzidi K, Elamin W, Kranzer K, Irish D, Ferns B, Kennedy P . Hepatitis delta virus testing, epidemiology and management: a multicentre cross-sectional study of patients in London. J Clin Virol. 2015; 66:33-7. DOI: 10.1016/j.jcv.2015.02.011. View

Jin W, Lin Z, Xin Y, Jiang X, Dong Q, Xuan S . Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterol. 2012; 12:14. PMC: 3306191. DOI: 10.1186/1471-230X-12-14. View

Asif B, Koh C . Hepatitis D virus (HDV): investigational therapeutic agents in clinical trials. Expert Opin Investig Drugs. 2021; 31(9):905-920. PMC: 11391510. DOI: 10.1080/13543784.2021.1977795. View

Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C . Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology. 2005; 41(6):1376-82. DOI: 10.1002/hep.20717. View

Sarin S, Kumar M, Lau G, Abbas Z, Chan H, Chen C . Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2015; 10(1):1-98. PMC: 4722087. DOI: 10.1007/s12072-015-9675-4. View

Braga W, de Oliveira C, de Araujo J, da Costa Castilho M, Martins Rocha J, de Lima Gimaque J . Chronic HDV/HBV co-infection: predictors of disease stage---a case series of HDV-3 patients. J Hepatol. 2014; 61(6):1205-11. DOI: 10.1016/j.jhep.2014.05.041. View

OMalley B, Lazinski D . Roles of carboxyl-terminal and farnesylated residues in the functions of the large hepatitis delta antigen. J Virol. 2004; 79(2):1142-53. PMC: 538544. DOI: 10.1128/JVI.79.2.1142-1153.2005. View

Xiao G, Yang J, Yan L . Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology. 2014; 61(1):292-302. DOI: 10.1002/hep.27382. View

10.

De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C . Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022; 76(4):959-974. PMC: 11090185. DOI: 10.1016/j.jhep.2021.12.022. View

11.

Buti M, Esteban R, Jardi R, Esteban J, Guardia J . Serological diagnosis of acute delta hepatitis. J Med Virol. 1986; 18(1):81-5. DOI: 10.1002/jmv.1890180110. View

12.

Schaper M, Rodriguez-Frias F, Jardi R, Tabernero D, Homs M, Ruiz G . Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. J Hepatol. 2010; 52(5):658-64. DOI: 10.1016/j.jhep.2009.10.036. View

13.

Huovila A, Eder A, Fuller S . Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment. J Cell Biol. 1992; 118(6):1305-20. PMC: 2289601. DOI: 10.1083/jcb.118.6.1305. View

14.

Wranke A, Heidrich B, Ernst S, Serrano B, Caruntu F, Curescu M . Anti-HDV IgM as a marker of disease activity in hepatitis delta. PLoS One. 2014; 9(7):e101002. PMC: 4114528. DOI: 10.1371/journal.pone.0101002. View

15.

Takyar V, Surana P, Kleiner D, Wilkins K, Hoofnagle J, Liang T . Noninvasive markers for staging fibrosis in chronic delta hepatitis. Aliment Pharmacol Ther. 2016; 45(1):127-138. PMC: 5135658. DOI: 10.1111/apt.13834. View

16.

Wang C, Chen P, Wu J, Patel D, Chen D . Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles. J Virol. 1991; 65(12):6630-6. PMC: 250729. DOI: 10.1128/JVI.65.12.6630-6636.1991. View

17.

Lai M . The molecular biology of hepatitis delta virus. Annu Rev Biochem. 1995; 64:259-86. DOI: 10.1146/annurev.bi.64.070195.001355. View

18.

Yamashiro T, Nagayama K, Enomoto N, Watanabe H, Miyagi T, Nakasone H . Quantitation of the level of hepatitis delta virus RNA in serum, by real-time polymerase chain reaction--and its possible correlation with the clinical stage of liver disease. J Infect Dis. 2004; 189(7):1151-7. DOI: 10.1086/382133. View

19.

Scholtes C, Icard V, Amiri M, Chevallier-Queyron P, Trabaud M, Ramiere C . Standardized one-step real-time reverse transcription-PCR assay for universal detection and quantification of hepatitis delta virus from clinical samples in the presence of a heterologous internal-control RNA. J Clin Microbiol. 2012; 50(6):2126-8. PMC: 3372137. DOI: 10.1128/JCM.06829-11. View

20.

Mederacke I, Bremer B, Heidrich B, Kirschner J, Deterding K, Bock T . Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics. J Clin Microbiol. 2010; 48(6):2022-9. PMC: 2884474. DOI: 10.1128/JCM.00084-10. View